MSM

References

1. ^ a b Gumina S, et al. Arginine L-alpha-ketoglutarate, methylsulfonylmethane, hydrolyzed type I collagen and bromelain in rotator cuff tear repair: a prospective randomized study. Curr Med Res Opin. (2012)
2. ^ a b Joksimovic N, et al. Efficacy and tolerability of hyaluronic acid, tea tree oil and methyl-sulfonyl-methane in a new gel medical device for treatment of haemorrhoids in a double-blind, placebo-controlled clinical trial. Updates Surg. (2012)
3. ^ a b Berardesca E, et al. Combined effects of silymarin and methylsulfonylmethane in the management of rosacea: clinical and instrumental evaluation. J Cosmet Dermatol. (2008)
4. ^ a b c [No authors listed. Methylsulfonylmethane (MSM). Monograph. Altern Med Rev. (2003)
5. ^ a b c d e f Brien S, et al. Systematic review of the nutritional supplements dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) in the treatment of osteoarthritis. Osteoarthritis Cartilage. (2008)
6. ^ a b c d e f g h Magnuson BA, Appleton J, Ames GB. Pharmacokinetics and distribution of {35S}methylsulfonylmethane following oral administration to rats. J Agric Food Chem. (2007)
7. ^ El-Gindy A, et al. Reflectance near-infrared spectroscopic method with Chemometric techniques for simultaneous determination of Chondroitin, glucosamine, and methyl sulfonyl methane. J AOAC Int. (2012)
8. ^ Tsui T, et al. Understanding the role of scientific evidence in consumer evaluation of natural health products for osteoarthritis an application of the means end chain approach. BMC Complement Altern Med. (2012)
9. ^ Clark T, et al. Why are dimethyl sulfoxide and dimethyl sulfone such good solvents. J Mol Model. (2008)
10. ^ a b Williams KI, Burstein SH, Layne DS. Dimethyl sulfone: isolation from cows’ milk. Proc Soc Exp Biol Med. (1966)
11. ^ a b c d e f g h i j k Pearson TW, Dawson HJ, Lackey HB. Natural occurring levels of dimethyl sulfoxide in selected fruits, vegetables, grains, and beverages. J Agric Food Chem. (1981)
12. ^ GC-MS identification of dimethyl sulfone in cow’s milk and other livestock products.
13. ^ a b Smale BC, Lasater NJ, Hunter BT. Fate and metabolism of dimethyl sulfoxide in agricultural crops. Ann N Y Acad Sci. (1975)
14. ^ Egorin MJ, et al. Plasma concentrations and pharmacokinetics of dimethylsulfoxide and its metabolites in patients undergoing peripheral-blood stem-cell transplants. J Clin Oncol. (1998)
15. ^ Engelke UF, et al. Dimethyl sulfone in human cerebrospinal fluid and blood plasma confirmed by one-dimensional (1)H and two-dimensional (1)H-(13)C NMR. NMR Biomed. (2005)
16. ^ Burger BV, et al. Elemental sulfur identified in urine of cheetah, Acinonyx jubatus. J Chem Ecol. (2006)
17. ^ Apps P, Mmualefe L, McNutt JW. Identification of volatiles from the secretions and excretions of African wild dogs (Lycaon pictus). J Chem Ecol. (2012)
18. ^ Williams KI, Burstein SH, Layne DS. Metabolism of dimethyl sulfide, dimethyl sulfoxide, and dimethyl sulfone in the rabbit. Arch Biochem Biophys. (1966)
19. ^ Richmond VL. Incorporation of methylsulfonylmethane sulfur into guinea pig serum proteins. Life Sci. (1986)
20. ^ Elucidation of dimethylsulfone metabolism in rat using a 35S radioisotope tracer method.
21. ^ Cecil KM, et al. Methylsulfonylmethane observed by in vivo proton magnetic resonance spectroscopy in a 5-year-old child with developmental disorder: effects of dietary supplementation. J Comput Assist Tomogr. (2002)
22. ^ a b c d Lin A, et al. Accumulation of methylsulfonylmethane in the human brain: identification by multinuclear magnetic resonance spectroscopy. Toxicol Lett. (2001)
23. ^ a b c Rose SE, et al. Detection of dimethyl sulfone in the human brain by in vivo proton magnetic resonance spectroscopy. Magn Reson Imaging. (2000)
24. ^ Willemsen MA, et al. Methylsulfonylmethane (MSM) ingestion causes a significant resonance in proton magnetic resonance spectra of brain and cerebrospinal fluid. Neuropediatrics. (2006)
25. ^ Rogovin JL. Accumulation of methylsulfonylmethane in the human brain: identification by multinuclear magnetic resonance spectroscopy. Toxicol Lett. (2002)
26. ^ Evans MS, Reid KH, Sharp JB Jr. Dimethylsulfoxide (DMSO) blocks conduction in peripheral nerve C fibers: a possible mechanism of analgesia. Neurosci Lett. (1993)
27. ^ Bal E, et al. The effects of gender difference on monocrotaline-induced pulmonary hypertension in rats. Hum Exp Toxicol. (2013)
28. ^ Werchan PM, et al. Right ventricular performance after monocrotaline-induced pulmonary hypertension. Am J Physiol. (1989)
29. ^ a b c Mohammadi S, et al. Protective effects of methylsulfonylmethane on hemodynamics and oxidative stress in monocrotaline-induced pulmonary hypertensive rats. Adv Pharmacol Sci. (2012)
30. ^ a b Parcell S. Sulfur in human nutrition and applications in medicine. Altern Med Rev. (2002)
31. ^ Jin HF, et al. Effects of endogenous sulfur dioxide on monocrotaline-induced pulmonary hypertension in rats. Acta Pharmacol Sin. (2008)
32. ^ Kantor ED, et al. Association between use of specialty dietary supplements and C-reactive protein concentrations. Am J Epidemiol. (2012)
33. ^ Klandorf H, et al. Dimethyl sulfoxide modulation of diabetes onset in NOD mice. Diabetes. (1989)
34. ^ Brayton CF. Dimethyl sulfoxide (DMSO): a review. Cornell Vet. (1986)
35. ^ Feng L, et al. Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide. J Clin Invest. (1995)
36. ^ Kloesch B, et al. Dimethyl sulphoxide and dimethyl sulphone are potent inhibitors of IL-6 and IL-8 expression in the human chondrocyte cell line C-28/I2. Life Sci. (2011)
37. ^ Kim YH, et al. The anti-inflammatory effects of methylsulfonylmethane on lipopolysaccharide-induced inflammatory responses in murine macrophages. Biol Pharm Bull. (2009)
38. ^ a b c Ezaki J, et al. Assessment of safety and efficacy of methylsulfonylmethane on bone and knee joints in osteoarthritis animal model. J Bone Miner Metab. (2013)
39. ^ Rizzo R, et al. Calcium, sulfur, and zinc distribution in normal and arthritic articular equine cartilage: a synchrotron radiation-induced X-ray emission (SRIXE) study. J Exp Zool. (1995)
40. ^ Burdett N, McNeil JD. Difficulties with assessing the benefit of glucosamine sulphate as a treatment for osteoarthritis. Int J Evid Based Healthc. (2012)
41. ^ Cordoba F, Nimni ME. Chondroitin sulfate and other sulfate containing chondroprotective agents may exhibit their effects by overcoming a deficiency of sulfur amino acids. Osteoarthritis Cartilage. (2003)
42. ^ Barrager E, et al. A multicentered, open-label trial on the safety and efficacy of methylsulfonylmethane in the treatment of seasonal allergic rhinitis. J Altern Complement Med. (2002)
43. ^ Gaby AR. Methylsulfonylmethane as a treatment for seasonal allergic rhinitis: more data needed on pollen counts and questionnaire. J Altern Complement Med. (2002)
44. ^ Barrager E, Schauss AG. Methylsulfonylmethane as a treatment for seasonal allergic rhinitis: additional data on pollen counts and symptom questionnaire. J Altern Complement Med. (2003)
45. ^ Kalman DS, et al. Influence of methylsulfonylmethane on markers of exercise recovery and performance in healthy men: a pilot study. J Int Soc Sports Nutr. (2012)
46. ^ Barmaki S, et al. Effect of methylsulfonylmethane supplementation on exercise – Induced muscle damage and total antioxidant capacity. J Sports Med Phys Fitness. (2012)
47. ^ Nakhostin-Roohi B, et al. Effect of chronic supplementation with methylsulfonylmethane on oxidative stress following acute exercise in untrained healthy men. J Pharm Pharmacol. (2011)
48. ^ a b c Kim LS, et al. Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial. Osteoarthritis Cartilage. (2006)
49. ^ a b Usha PR, Naidu MU. Randomised, Double-Blind, Parallel, Placebo-Controlled Study of Oral Glucosamine, Methylsulfonylmethane and their Combination in Osteoarthritis. Clin Drug Investig. (2004)
50. ^ a b Debbi EM, et al. Efficacy of methylsulfonylmethane supplementation on osteoarthritis of the knee: a randomized controlled study. BMC Complement Altern Med. (2011)
51. ^ Geba GP, et al. Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial. JAMA. (2002)
52. ^ Notarnicola A, et al. The “MESACA” study: methylsulfonylmethane and boswellic acids in the treatment of gonarthrosis. Adv Ther. (2011)
53. ^ a b c Joung YH, et al. MSM enhances GH signaling via the Jak2/STAT5b pathway in osteoblast-like cells and osteoblast differentiation through the activation of STAT5b in MSCs. PLoS One. (2012)
54. ^ Jafari N, et al. Cytotoxicity of methylsulfonylmethane on gastrointestinal (AGS, HepG2, and KEYSE-30) cancer cell lines. J Gastrointest Cancer. (2012)
55. ^ a b c d e Lim EJ, et al. Methylsulfonylmethane suppresses breast cancer growth by down-regulating STAT3 and STAT5b pathways. PLoS One. (2012)
56. ^ a b c Caron JM, et al. Methyl sulfone induces loss of metastatic properties and reemergence of normal phenotypes in a metastatic cloudman S-91 (M3) murine melanoma cell line. PLoS One. (2010)
57. ^ Yi HK, et al. Expression of the insulin-like growth factors (IGFs) and the IGF-binding proteins (IGFBPs) in human gastric cancer cells. Eur J Cancer. (2001)
58. ^ Hwang PH, et al. PTEN/MMAC1 enhances the growth inhibition by anticancer drugs with downregulation of IGF-II expression in gastric cancer cells. Exp Mol Med. (2005)
59. ^ Ben-Porath I, Weinberg RA. The signals and pathways activating cellular senescence. Int J Biochem Cell Biol. (2005)
60. ^ Lleonart ME, Artero-Castro A, Kondoh H. Senescence induction; a possible cancer therapy. Mol Cancer. (2009)
61. ^ Roninson IB. Tumor cell senescence in cancer treatment. Cancer Res. (2003)
62. ^ Amirshahrokhi K, Bohlooli S, Chinifroush MM. The effect of methylsulfonylmethane on the experimental colitis in the rat. Toxicol Appl Pharmacol. (2011)
63. ^ a b Tripathi R, et al. Effect of topical application of methylsulfonylmethane (MSM), EDTA on pitting edema and oxidative stress in a double blind, placebo-controlled study. Cell Mol Biol (Noisy-le-grand). (2011)
64. ^ Berardesca E, et al. Clinical and instrumental evaluation of skin improvement after treatment with a new 50% pyruvic acid peel. Dermatol Surg. (2006)
65. ^ Kurihara-Bergstrom T, Flynn GL, Higuchi WI. Physicochemical study of percutaneous absorption enhancement by dimethyl sulfoxide: kinetic and thermodynamic determinants of dimethyl sulfoxide mediated mass transfer of alkanols. J Pharm Sci. (1986)
66. ^ Mode of action of penetration enhancers in human skin.
67. ^ KLIGMAN AM. TOPICAL PHARMACOLOGY AND TOXICOLOGY OF DIMETHYL SULFOXIDE. 1. JAMA. (1965)
68. ^ Sweeney TM, Downes AM, Matoltsy AG. The effect of dimethyl sulfoxide on the epidermal water barrier. J Invest Dermatol. (1966)
69. ^ Montes LF, et al. Ultrastructural changes in the horny layer following local application of dimethyl sulfoxide. J Invest Dermatol. (1967)
70. ^ Shackleford JM, Yielding KL. Ultrastructural studies of barrier restoration in epidermis of hairless mice following dimethyl sulfoxide application. J Cutan Pathol. (1984)
71. ^ Song Y, et al. Investigation of iminosulfuranes as novel transdermal penetration enhancers: enhancement activity and cytotoxicity. Pharm Res. (2005)
72. ^ a b c d e Zhang M, et al. Assessment of methylsulfonylmethane as a permeability enhancer for regional EDTA chelation therapy. Drug Deliv. (2009)
73. ^ Zhang M, et al. Topical metal chelation therapy ameliorates oxidation-induced toxicity in diabetic cataract. J Toxicol Environ Health A. (2011)
74. ^ Horváth K, et al. Toxicity of methylsulfonylmethane in rats. Food Chem Toxicol. (2002)
75. ^ Magnuson BA, et al. Oral developmental toxicity study of methylsulfonylmethane in rats. Food Chem Toxicol. (2007)